Novel biomarkers for Hepatocellular carcinoma (HCC)

Item Number: 644
Industry: Therapeutic
Category: Oncology
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Patent: Korea
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The present invention relates to hepatocellular carcinoma (HCC) specific biomarkers. More particularly, it includes biomarkers to detect and diagnose HCC by using genes whose expression levels change specific to HCC.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it